Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IGSF8 anticorps (Middle Region)

IGSF8 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN929376
  • Antigène Voir toutes IGSF8 Anticorps
    IGSF8 (Immunoglobulin Superfamily, Member 8 (IGSF8))
    Épitope
    • 16
    • 11
    • 8
    • 7
    • 7
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reactivité
    • 44
    • 38
    • 7
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 43
    • 8
    Lapin
    Clonalité
    • 44
    • 7
    Polyclonal
    Conjugué
    • 19
    • 5
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp IGSF8 est non-conjugé
    Application
    • 43
    • 24
    • 22
    • 15
    • 13
    • 13
    • 7
    • 5
    • 3
    • 1
    Western Blotting (WB)
    Purification
    Purified
    Immunogène
    IGSF8 antibody was raised in rabbit using the middle region of IGSF8 as the immunogen
    Top Product
    Discover our top product IGSF8 Anticorps primaire
  • Indications d'application
    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.
    Commentaires

    IGSF8 Blocking Peptide, catalog no. 33R-4805, is also available for use as a blocking control in assays to test for specificity of this IGSF8 antibody

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    Lot specific
    Buffer
    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Antigène
    IGSF8 (Immunoglobulin Superfamily, Member 8 (IGSF8))
    Autre désignation
    IGSF8 (IGSF8 Produits)
    Synonymes
    anticorps MGC77222, anticorps IGSF8, anticorps MGC151661, anticorps CD316, anticorps CD81P3, anticorps EWI-2, anticorps EWI2, anticorps KCT-4, anticorps LIR-D1, anticorps PGRL, anticorps AA033172, anticorps AU041109, anticorps ESTM34, anticorps R75384, anticorps immunoglobulin superfamily, member 8, anticorps immunoglobulin superfamily member 8, anticorps igsf8, anticorps IGSF8, anticorps Igsf8
    Sujet
    IGSF8 may play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function. IGSF8 may regulate proliferation and differentiation of keratinocytes. IGSF8 may be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers. IGSF8 may also play a role on integrin-dependent morphology and motility functions. IGSF8 may participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain. Synonyms: Polyclonal IGSF8 antibody, Anti-IGSF8 antibody, immunoglobulin superfamily, member 8 antibody, CD316 antibody, CD81P3 antibody, EWI2 antibody, PGRL antibody.
Vous êtes ici:
Support technique